Price T Rowe Associates Inc. MD Purchases 55,781 Shares of Cardinal Health, Inc. (NYSE:CAH)

Price T Rowe Associates Inc. MD increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,601,322 shares of the company’s stock after purchasing an additional 55,781 shares during the period. Price T Rowe Associates Inc. MD owned 0.66% of Cardinal Health worth $189,390,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CAH. Barclays PLC raised its stake in Cardinal Health by 8.2% in the 3rd quarter. Barclays PLC now owns 707,404 shares of the company’s stock valued at $78,183,000 after acquiring an additional 53,851 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Cardinal Health in the third quarter valued at about $846,000. Franklin Resources Inc. lifted its stake in shares of Cardinal Health by 6.6% during the 3rd quarter. Franklin Resources Inc. now owns 151,185 shares of the company’s stock worth $16,918,000 after buying an additional 9,385 shares during the last quarter. Oddo BHF Asset Management Sas bought a new stake in shares of Cardinal Health during the 3rd quarter worth about $497,000. Finally, Copley Financial Group Inc. acquired a new position in Cardinal Health in the 3rd quarter valued at about $507,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH opened at $137.64 on Friday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $139.50. The firm has a market cap of $33.25 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 1.49 and a beta of 0.61. The business’s fifty day moving average is $130.82 and its 200-day moving average is $124.02.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were issued a dividend of $0.5056 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.47%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CAH shares. Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Bank of America boosted their price target on Cardinal Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, April 11th. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Mizuho boosted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a research report on Monday, March 31st. Finally, Wells Fargo & Company raised their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $140.86.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.